Compare AVXL & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | RELL |
|---|---|---|
| Founded | 2004 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 250.1M |
| IPO Year | 2013 | 2004 |
| Metric | AVXL | RELL |
|---|---|---|
| Price | $3.56 | $16.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 842.7K | 297.3K |
| Earning Date | 05-08-2026 | 04-08-2026 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $228,564,000.00 |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $7.91 |
| P/E Ratio | ★ N/A | $230.96 |
| Revenue Growth | N/A | ★ 9.41 |
| 52 Week Low | $2.26 | $9.37 |
| 52 Week High | $10.40 | $23.15 |
| Indicator | AVXL | RELL |
|---|---|---|
| Relative Strength Index (RSI) | 64.61 | 39.18 |
| Support Level | $3.53 | $16.57 |
| Resistance Level | $3.76 | $17.65 |
| Average True Range (ATR) | 0.16 | 0.91 |
| MACD | -0.00 | -0.48 |
| Stochastic Oscillator | 98.98 | 9.82 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.